Terms: = Germ cell tumor AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43 AND Prognosis
12 results:
1. Explore the impact of hypoxia-related genes (HRGs) in Cutaneous melanoma.
Ke G; Cheng N; Sun H; Meng X; Xu L
BMC Med Genomics; 2023 Jul; 16(1):160. PubMed ID: 37422626
[TBL] [Abstract] [Full Text] [Related]
2. The Myc Family and the Metastasis Suppressor ndrg1: Targeting Key Molecular Interactions with Innovative Therapeutics.
Deng Z; Richardson DR
Pharmacol Rev; 2023 Sep; 75(5):1007-1035. PubMed ID: 37280098
[TBL] [Abstract] [Full Text] [Related]
3. The Influence of ndrg1 Single Nucleotide Polymorphisms on Glioma Risk and prognosis in Chinese Han Population.
Yang Y; Cheng Y; Yang L; Shi G; Chen P; Li L; Fang H; Chen C; Jin T
Cell Mol Neurobiol; 2022 Aug; 42(6):1949-1964. PubMed ID: 33709284
[TBL] [Abstract] [Full Text] [Related]
4. The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma.
Song LB; Luan JC; Zhang QJ; Chen L; Wang HY; Cao XC; Song NH; Lu Y
J Immunol Res; 2021; 2021():6686284. PubMed ID: 33688507
[TBL] [Abstract] [Full Text] [Related]
5. Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus.
Viúdez A; Crespo G; Gómez Dorronsoro ML; Arozarena I; Marín-Méndez JJ; Custodio A; Benavent M; Goñi S; García-Paredes B; Hernando J; Durantez M; Alonso V; Riesco MDC; López C; Jiménez-Fonseca P; San Vicente BL; González-Borja I; Sevilla I; Hernández-Garcia I; Carmona-Bayonas A; Capdevila J; Pérez-Sanz J; García-Carbonero R; Pérez-Ricarte L; Llanos M; Vera R; De Jesús Acosta A
Pancreatology; 2021 Jan; 21(1):215-223. PubMed ID: 33358592
[TBL] [Abstract] [Full Text] [Related]
6. Bidirectional Regulation between ndrg1 and GSK3β Controls tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.
Ito H; Watari K; Shibata T; Miyamoto T; Murakami Y; Nakahara Y; Izumi H; Wakimoto H; Kuwano M; Abe T; Ono M
Cancer Res; 2020 Jan; 80(2):234-248. PubMed ID: 31723002
[TBL] [Abstract] [Full Text] [Related]
7. ndrg1 promotes the multidrug resistance of neuroblastoma cells with upregulated expression of drug resistant proteins.
Zhang D; Jia J; Zhao G; Yue M; Yang H; Wang J
Biomed Pharmacother; 2015 Dec; 76():46-51. PubMed ID: 26653549
[TBL] [Abstract] [Full Text] [Related]
8. Low ndrg1 mRNA expression predicts a poor prognosis in neuroblastoma patients.
Matsushita K; Uchida K; Saigusa S; Ide S; Hashimoto K; Koike Y; Otake K; Inoue M; Tanaka K; Kusunoki M
Pediatr Surg Int; 2013 Apr; 29(4):363-8. PubMed ID: 23296375
[TBL] [Abstract] [Full Text] [Related]
9. Expression of N-myc downstream regulated gene 1 (ndrg1) in central neurocytoma.
Fotovati A; Abu-Ali S; Sugita Y; Nakamura Y
J Clin Neurosci; 2011 Oct; 18(10):1383-5. PubMed ID: 21784644
[TBL] [Abstract] [Full Text] [Related]
10. Decreased expression of ndrg1 in glioma is related to tumor progression and survival of patients.
Sun B; Chu D; Li W; Chu X; Li Y; Wei D; Li H
J Neurooncol; 2009 Sep; 94(2):213-9. PubMed ID: 19337694
[TBL] [Abstract] [Full Text] [Related]
11. Immunohistochemical expressions of cap43 and Mina53 proteins in neuroblastoma.
Fukahori S; Yano H; Tsuneoka M; Tanaka Y; Yagi M; Kuwano M; Tajiri T; Taguchi T; Tsuneyoshi M; Kojiro M
J Pediatr Surg; 2007 Nov; 42(11):1831-40. PubMed ID: 18022432
[TBL] [Abstract] [Full Text] [Related]
12. The growth-inhibitory ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N- or c-myc.
Li J; Kretzner L
Mol Cell Biochem; 2003 Aug; 250(1-2):91-105. PubMed ID: 12962147
[TBL] [Abstract] [Full Text] [Related]
